Member Info for chester18

Morning TF

The fact that they have found the memory 'T Cells' should give us all a little more confidence that we can regain most of what we thought was normal life. The issues are that we can still become infectious and pass Covid on to those whose immune system isn't that great. Also, this is all a very mute point in countries where only 5 or 10% have been vaccinated.
Some countries have been vaccinated with very low quality vaccines and the double jabbed are still dieing of Covid.

My wish is that the second generation Vax's produce an ongoing clearance of the virus, meaning less chance of incubating and passing it on. I hope the Scancell platform is one of those important break through's.

Chester.

All the best C7

I will be thinking about you all day.

Chester.

Given that we are in the middle of a global pandemic speed is paramount, Covidity should be moving forward at a good pace.
From the approval by SAHPRA on the 29th July I'm allowing 21-28 days to set up the clinic.

Any delay at this stage is unacceptable as this should all have been prepped and planned whilst waiting for the Approval to come through.

Therefore I would hope that the First Subject will be dosed this week with a Trial Started RNS by this Friday.

Chester.

The continued under valuing of Greatland Gold at the same time as the True Value increases with every Drill Crew shift, means that the SP has the nature of a coiled spring.

With the current price so low and the PFS so close, the return of the early Exploration cores from the Labs in days or weeks and now we know that the actual mineral footprint of Havieron is growing Sideways as well as at Depth. Newcrest talking about the Gold / Copper Trending NorthWest, not that it's a possibility but expressing it as if it is a fact.

This 17p a share is like 'Happy Hour' as once any of the above becomes proven the true price will be put back in place. ( 27p to 30p )

Six months from now this period of gathering cheap shares will put a smile on some faces and green envy on others......

Chester.

Starting Monday traders can buy on a T10 note giving them a possible trade with profit by the 7th Sept.

If you look back at previous Drill Core Reports the price rises towards the next news usually peaking lunchtime ish on the Wednesday.

My hope is that this next report is a bumper crop and creates real growth excitement as we move towards the all important PFS....

ATB

Chester.

OK I accept some people will be nervous and worry 'what if Covidity is toxic and doesn't work as well as it should' and all because they don't have a Scooby Doo about the history of Scancell's Science.

The lab work will have been vigorous and the construct tested, tested, tested. The Safety and Dose Size part of the Trial is extremely important as it will be the first time it's been inside and working in the Human Immune System. It is however predominantly the Immunobody used in the SCIB1 trial that proved non toxic so I'm not concerned at all.

For me it's all about how well the delivery system works and does it generate the High Avidity T Cell response that will set Covidity on the path to becoming the future Covid Vax of choice.

Chester.

As we know the Moditope platform was very nearly trial ready.

This has idea been mentioned before but we haven't discussed in any detail :

Could it be that the delay from H1/21 to H2/21 is due to the very positive Covidity lab data when using the PharmaJet delivery system.

I would not be surprised if LD pulled the trial based on a peptide delivery and insisted time be taken to incorporate the PharmaJet.
It would also fit with the sudden departure of CH.

I would like to hear some other opinions on that theory as it always helps to challenge assumptions.

Chester.

To start the trial all subjects will be screened prior to their Covidity Pharmajet shot.

As you point out anyone with pre-existing Covid19 antibodies could skew the results so they will be rejected. These pre-trial blood test will be all part of the Trial Set-up including quick turnaround lab test.

I'm expecting the next RNS to be Trial Started before the end of next week based on 4 weeks since approval and the fact that the PharmaJet tie up has finally been announced.

Chester.

DGR1980

Hadn't thought about it being the Warrants but that is a very strong possibility given that they expire next week.

Chester.

This selling pressure doesn't stack up with the reality of what is about to be reported on the 9th Sept by Newcrest.

We know because SD told us, that there are 15 cores plus any returns from the labs during July. That's a lot of new drilling data probably covering both infill and growth targets.

Add to this the potential of some Exploration news, as there are several GGP cores due back anytime.

This feels like a definite final push to force out the weak and nervous.

Chester

I'm also wondering if Sky News are following the Scancell journey like the BBC did with the Oxford Vax.

The Sky reporter was really on the ball with our science and the potential of Covidity for future proofing vaccines against Covid strains.

Would be fantastic if true and an opportunity missed by Sky if not.

Chester.

Ok thanks WTP,

We've waited a long time to see some clinical data and it's getting very close now.

Chester.

Hi WTP

Does that mean the Big Article has to wait until the SA trial produces that data, is that what he means ??

Chester.

We need Newspaper and TV coverage to generate the interest as we already saw at the beginning of the year.

That coverage is coming, either with Positive Safety Data released or once the South Africa trial shows the extent of Antibody and T Cell Responses, especially towards the N protein.

As Inanaco always said : Tick Tock

When the news arrives that causes the tipping point it will be
'how many shares you own that counts'

Chester.

I think most of us on these boards forget that the wider audience of potential Scancell shareholders don't know we exist.

We need newspaper and TV

Taverham rein it in !

The trial approval was RNSed on the 28th July how fast do you expect this to move forward.

Chester

The timing of this release tells me that the clinics in SA are now ready to begin their first injections.
The Pharmajet tie up has been kept in wraps until the last possible minute. News on first subject dosed within a week is my take on this RNS.

Excellent news

Chester.

What is the research you have done that makes you believe that shareholders will sell lower and lower when every single day the value of Havieron is going up ?

I'm very interested to understand your insights on the current dynamics of this stock.

Chester.

Whilst we await news on SA Covidity progress let's not forget that we should be in the clinic with Moditope by now. The continued statement in company RNS's at the end of 2020 and all through H1 2021 was "trial application by H1/21".

That delay and the fact that we have not had any explanation offered up as to why, now makes me wonder if this is the true reason for the departure of Dr. Cliff Holloway.

MODI1 for me is the main reason why I invested in Scancell and I will be lot happier once we know the application has been submitted.

If we do not hear any news on this front by the end of August I think we need to contact Scancell on mass and see if we can obtain some new information about when things will begin to move forward with MODI1.

Chester.

Hi TMT, my wish for you is that you find fulfilment and contentment through your good work. I also feel that the people who meet you in your future role will be the fortunate ones.

Good luck in all your endeavours.

Chester.